CMS is about to start a 10-year experiment that could matter more to healthcare AI startups than another model launch. The agency's ACCESS model, beginning July 5, 2026, is designed to test outcome-aligned payments in Original Medicare for technology-supported care used to prevent and manage chronic disease.

What CMS is testing

According to CMS, ACCESS is meant to remove payment barriers that have limited technology-supported care in Medicare. Instead of paying only for clinician time or a fixed list of billable activities, the model gives participating organizations a way to be paid for helping patients meet health goals across conditions such as hypertension, diabetes, chronic musculoskeletal pain, and depression.

TechCrunch reported that health-tech founders see that structure as an opening for AI systems that can monitor, coordinate, and follow up with patients between visits. Pair Team, which announced on April 30 that it had been accepted into the model, said its AI health advocate Flora handles intake, coordination, and patient check-ins outside the clinic.

Why it matters

The cautious read is that ACCESS is not an AI program. CMS describes it as a test of technology-supported care, and its real-world effect will depend on outcomes, privacy safeguards, and whether participants can actually deliver better care at the reimbursement levels on offer.

Even so, the payment design matters. Medicare has historically struggled to reimburse software-driven care that happens between appointments. If ACCESS works, it could become one of the clearest federal pathways yet for AI-supported chronic-care businesses to get paid inside mainstream healthcare.